ACCOUNT

Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

PGe
NEWSLETTERS
PG STORE
ARCHIVES

CLASSIFIEDS

OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS

CONTACT US
ADVERTISING
CAREER OPPORTUNITIES

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bayer Aktienges ADR (OP:BAYRY)

12.09 +0.75 (+6.61%)

Streaming Delayed Price Updated: 3:59 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bayer Aktienges ADR

< Previous 1 2 3 4 5 6 7 8 Next >

Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study ↗

June 28, 2023

Bayer AG (OTC: BAYRY) (OTC: BAYZF) and its subsidiary BlueRock Therapeutics LP announced

Via Benzinga

Experimental Stem Cell Therapy For Parkinson's Shows Promise in Phase I Trial: Reuters ↗

June 28, 2023

Via Benzinga

Regeneron Stock Crumbles After FDA Rejects Its Next Blockbuster Contender ↗

June 27, 2023

The FDA still needs to review its inspection of a third-party facility, Regeneron said late Tuesday.

Via Investor's Business Daily

Fusion Pharmaceuticals is Future Pillar of Cancer Treatment: Analyst ↗

June 23, 2023

Raymond James has initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN) with an Outperform rating and a

Via Benzinga

There’s Only One Way To Beat The Market ↗

June 12, 2023

The way Wall Street makes money has fundamentally shifted in recent years. So has the way information flows to individual investors. Today, I want to show you how savvy stock pickers can profit from...

Via Talk Markets

Daily Stock Analysis: Bayer AG - May '23 Update ↗

May 17, 2023

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as over the counter products.

Via Talk Markets

Bayer: Aspirin To Crop Protection ↗

December 18, 2022

Pharmaceutical drugs account for 41% of Bayer's revenues and include Xarelto, Eylea, Mirena, Kogenate and Nexavar. Its OTC product lineup is filled with household names like Aleve, Alka Seltzer,...

Via Talk Markets

Unmasking Q2 2023's Stars & Strugglers: Industry ETFs And Top Stock Standouts ↗

June 27, 2023

Via Benzinga

Perrigo Picks Former Bayer Executive As New CEO ↗

June 08, 2023

Perrigo Co PLC (NYSE: PRGO) disclosed the appointment of Patrick Lockwood-Taylor as its new President, CEO and member of the Board of Directors,

Via Benzinga

Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries ↗

April 27, 2023

Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...

Via Talk Markets

Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz ↗

April 24, 2023

Via Benzinga

After That Big Merger, What Happened? ↗

April 15, 2023

There are often substantial controversies over whether a merger should be allowed to happen, but then relatively little follow-up after the event.

Via Talk Markets

InvestorNewsBreaks – ROTH MKM’s Agribusiness Investment Banking Group Serves as Sellside Advisor for Three M&A Transactions

April 11, 2023

Via Investor Brand Network

Topics Derivatives

Russia Warns As Finland Joins NATO, Spotify Highlights Struggle With Live Audio, Anticompetitive Charges Against Activision Blizzard: Today's Top Stories ↗

April 04, 2023

Benzinga Finland Joins NATO Doubling Border Length, Russia Issues Warning

Via Benzinga

US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities ↗

April 04, 2023

Via Benzinga

Evogene Offers An Excellent Risk/Reward Ratio ↗

March 21, 2023

We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their...

Via Talk Markets

Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B ↗

March 10, 2023

Bayer AG (OTC: BAYRY) intends to shell out around $1 billion on drug research and development in the U.S. in 2023 as it works to double its sales in the U.S. over the next ten years.

Via Benzinga

EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue ↗

February 15, 2023

Cannabis companies of all sizes are struggling to increase their profit margins and to make that happen, they're implementing different strategies. Lowering prices and premiumizing products are among...

Via Benzinga

Bayer Snags Ex-Roche Exec Bill Anderson As New CEO; Shares Rocket ↗

February 08, 2023

Bill Anderson, who previously headed up Roche's pharma division, will take over June 1.

Via Investor's Business Daily

Investors Always Miss This Key Element ↗

January 30, 2023

Return on invested capital, or ROIC, is one of the most critical inputs needed to figure out the value of a company.

Via Talk Markets

Ring The Register; Plus, Where To Park Your Profits ↗

January 23, 2023

Sometimes an investment works out a lot quicker than expected. That’s the case with my July 2022 pick, Freeport-McMoRan Inc., the fourth-largest copper mining company in the world.

Via Talk Markets

Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm ↗

January 18, 2023

Via Benzinga

FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian Hit By Mass Executive Exodus: Today's Top Stories ↗

January 11, 2023

Reuters

Via Benzinga

Activist Investor Builds Stake In Bayer, Pushes Breakup ↗

January 11, 2023

Activist investor Bluebell Capital Partners has built a stake in Bayer AG (OTC: BAYRY) (OTC: BAYZF) and is pushing it to split up.

Via Benzinga

Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down ↗

December 19, 2022

MJBiz CEO To Step Down Marijuana Business Daily's Chris Walsh will step down as CEO in January.

Via Benzinga

Current Report: Bayer AG ↗

November 17, 2022

By my dogcatcher ideal, this may be a prime time to buy Bayer AG shares based on their dividends for the coming year 2022-23.

Via Talk Markets

Ionis Regains Rights To Thrombosis Candidate From Bayer ↗

November 04, 2022

Via Benzinga

Can Acquisitions and Partnerships Take Ginkgo Bioworks (DNA) Stock Higher? ↗

October 20, 2022

It seems that Ginkgo Bioworks is announcing a new acquisition or collaboration every day this month, putting DNA stock in focus.

Via InvestorPlace

What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today? ↗

October 18, 2022

AVEO stock jumped on the news that LG Chem will pay $15/share for Aveo Oncology and make it the centerpiece of a new oncology division.

Via InvestorPlace

Elon Musk Renews Twitter's Buyout Proposal, Apple Suppliers Working On Cutting China Reliance, E-Cigarette Maker Considers Bankruptcy: Top Stories Wednesday, Oct. 5 ↗

October 05, 2022

Wall Street Journal

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.